 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today announced that it has called an extraordinary general meeting of its shareholders (the Extraordinary General Meeting), to...

Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.

StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a research report sent to investors on Wednesday morning. The firm issued a strong-buy rating...

Taro Pharmaceutical Industries (NYSE:TARO) Earns Strong-Buy Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a strong-buy...

Taro Pharmaceutical Industries (NYSE:TARO) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO - Free Report) in a report released on Tuesday morning. The brokerage issued a strong-buy rating on the stock...

FNY Investment Advisers LLC purchased a new position in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO  Free Report) in the fourth quarter, according to its most recent filing with...

FNY Investment Advisers LLC Invests $105,000 in Taro Pharmaceutical Industries Ltd. (NYSE:TARO)

StockNews.com initiated coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO  Free Report) in a research note published on Monday morning. The brokerage issued a strong-buy rating...

Taro Pharmaceutical Industries (NYSE:TARO) Research Coverage Started at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO  Get Free Report) in a report issued on Monday. The brokerage set a...

StockNews.com Initiates Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

By Anna Edney | Bloomberg
Hand sanitizers were tainted by benzene. Sunscreens and dry shampoos too. Now acne treatments are joining the list of widely used consumer products found to contain high...

Chemical linked to cancer found in Proactiv, Clearasil and Clinique acne creams

Connor Clark & Lunn Investment Management Ltd. bought a new stake in Taro Pharmaceutical Industries Ltd. (NYSE:TARO  Free Report) during the 3rd quarter, according to the company in its most...

Connor Clark & Lunn Investment Management Ltd. Makes New Investment in Taro Pharmaceutical Industries Ltd. (NYSE:TARO)

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Volume (M)	15,038.00
52-Wk High	$45.76
52-Wk Low	$24.39

TARO Taro Pharmaceutical Industries

About

Feed

News

Sentiment

Earnings

Fundamentals